Acute Decompensated Heart Failure: Contemporary Medical Management

Overview

Journal Tex Heart Inst J

Specialty Cardiology & Vascular Diseases

Date 2010 Jan 14

PMID 20069075

Citations 54

Authors

Susan M Joseph

Ari M Cedars

Gregory A Ewald

Edward M Geltman

Douglas L Mann

Affiliations

Soon will be listed here.

Abstract

Hospitalizations for acute decompensated heart failure are increasing in the United States. Moreover, the prevalence of heart failure is increasing consequent to an increased number of older individuals, as well as to improvement in therapies for coronary artery disease and sudden cardiac death that have enabled patients to live longer with cardiovascular disease. The main treatment goals in the hospitalized patient with heart failure are to restore euvolemia and to minimize adverse events. Common in-hospital treatments include intravenous diuretics, vasodilators, and inotropic agents. Novel pharmaceutical agents have shown promise in the treatment of acute decompensated heart failure and may simplify the treatment and reduce the morbidity associated with the disease. This review summarizes the contemporary management of patients with acute decompensated heart failure.

Citing Articles

Association between oral loop diuretics duration before discharge and hospital readmission in acute decompensated heart failure: A multicenter retrospective cohort study.

Alshibani M, Alshehri S, Fatani N, Aljahdali S, Melibari N, Aljabri A Medicine (Baltimore). 2024; 103(49):e40834.

PMID: 39654234 PMC: 11631011. DOI: 10.1097/MD.0000000000040834.

Effect of Post-Loop Diuretic Urinary Sodium Level on Length of Stay and Rehospitalization in Acutely Decompensated Heart Failure Patients.

Soerarso R, Hasanah D, Yonas E, Tawari F, Raharjo S, Siswanto B Cardiol Res. 2024; 15(5):350-357.

PMID: 39420977 PMC: 11483111. DOI: 10.14740/cr1696.

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment.

Olverson 4th G, Higuita M, Bolger-Chen M, Ajenu E, Li S, Kharroubi H J Vis Exp. 2024; (210).

PMID: 39158286 PMC: 11815639. DOI: 10.3791/66624.

Prognostic utility of B-type natriuretic peptide and 6-min walk test in patients with acute decompensated heart failure.

Verma D, Nath R, Pandit N, Rahatekar P, Vatsa D, Bhutani M Indian Heart J. 2024; 76(4):291-296.

PMID: 39069072 PMC: 11451414. DOI: 10.1016/j.ihj.2024.07.011.

Establishment of in-hospital nutrition support program for middle-aged and elderly patients with acute decompendated heart failure.

Li Y, Zhu F, Ren D, Tong J, Xu Q, Zhong M BMC Cardiovasc Disord. 2024; 24(1):259.

PMID: 38762515 PMC: 11102219. DOI: 10.1186/s12872-024-03887-y.

References

Ahmed A, Allman R, Fonarow G, Love T, Zannad F, DellItalia L . Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail. 2008; 14(3):211-8. PMC: 2771194. DOI: 10.1016/j.cardfail.2007.12.001. View

Cuffe M, Califf R, Adams Jr K, Benza R, Bourge R, Colucci W . Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002; 287(12):1541-7. DOI: 10.1001/jama.287.12.1541. View

Nieminen M, Harjola V . Definition and epidemiology of acute heart failure syndromes. Am J Cardiol. 2005; 96(6A):5G-10G. DOI: 10.1016/j.amjcard.2005.07.015. View

Pitt B, Zannad F, Remme W, Cody R, CASTAIGNE A, Perez A . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341(10):709-17. DOI: 10.1056/NEJM199909023411001. View

Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y . Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure. Heart. 2006; 92(10):1434-40. PMC: 1861038. DOI: 10.1136/hrt.2005.079764. View

Dikshit K, Vyden J, Forrester J, Chatterjee K, Prakash R, Swan H . Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med. 1973; 288(21):1087-90. DOI: 10.1056/NEJM197305242882102. View

Cosin J, Diez J . Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail. 2002; 4(4):507-13. DOI: 10.1016/s1388-9842(02)00122-8. View

Fonarow G, Abraham W, Albert N, Stough W, Gheorghiade M, Greenberg B . Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med. 2008; 168(8):847-54. DOI: 10.1001/archinte.168.8.847. View

Hasselblad V, Stough W, Shah M, Lokhnygina Y, OConnor C, Califf R . Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007; 9(10):1064-9. PMC: 3127394. DOI: 10.1016/j.ejheart.2007.07.011. View

10.

Luss H, Mitrovic V, Seferovic P, Simeunovic D, Ristic A, Moiseyev V . Renal effects of ularitide in patients with decompensated heart failure. Am Heart J. 2008; 155(6):1012.e1-8. DOI: 10.1016/j.ahj.2008.02.011. View

11.

Cotter G, Moshkovitz Y, Milovanov O, Salah A, Blatt A, Krakover R . Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail. 2002; 4(3):227-34. DOI: 10.1016/s1388-9842(02)00017-x. View

12.

Brilla C, Matsubara L, Weber K . Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol. 1993; 25(5):563-75. DOI: 10.1006/jmcc.1993.1066. View

13.

Rogers H, Marshall J, Bock J, Dowling T, Feller E, Robinson S . A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail. 2008; 14(1):1-5. DOI: 10.1016/j.cardfail.2007.09.007. View

14.

Maisel A, Peacock W, McMullin N, Jessie R, Fonarow G, Wynne J . Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol. 2008; 52(7):534-40. DOI: 10.1016/j.jacc.2008.05.010. View

15.

Costanzo M, Guglin M, Saltzberg M, Jessup M, Bart B, Teerlink J . Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007; 49(6):675-83. DOI: 10.1016/j.jacc.2006.07.073. View

16.

Yancy C, Lopatin M, Stevenson L, De Marco T, Fonarow G . Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006; 47(1):76-84. DOI: 10.1016/j.jacc.2005.09.022. View

17.

PERLOFF J, Roberts W . The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation. 1972; 46(2):227-39. DOI: 10.1161/01.cir.46.2.227. View

18.

Nieminen M, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V . EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006; 27(22):2725-36. DOI: 10.1093/eurheartj/ehl193. View

19.

Schrier R, Gross P, Gheorghiade M, Berl T, Verbalis J, Czerwiec F . Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006; 355(20):2099-112. DOI: 10.1056/NEJMoa065181. View

20.

Liang K, Hiniker A, Williams A, Karon B, Greene E, Redfield M . Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail. 2006; 12(9):707-14. DOI: 10.1016/j.cardfail.2006.08.210. View